List of Ikena Oncology patents

List of Ikena Oncology patents

List of Myriad Women's Health, Inc. patents

List of NantWorks patents

List of Twist Bioscience patents

List of companies in Lakehouse Ventures's investment portfolio

List of funding rounds for Roper

Patents where

Current Assignee

Name

is

Ikena Oncology

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11760728 Tead inhibitors and uses thereof	Patent 11760728 was granted and assigned to Ikena Oncology on September, 2023 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11760728	September 19, 2023
	‌ US Patent 11555026 AHR inhibitors and uses thereof	Patent 11555026 was granted and assigned to Ikena Oncology on January, 2023 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11555026	January 17, 2023
	‌ US Patent 11274082 Tead inhibitors and uses thereof	Patent 11274082 was granted and assigned to Ikena Oncology on March, 2022 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11274082	March 15, 2022
	‌ US Patent 11458149 TEAD inhibitors and uses thereof	Patent 11458149 was granted and assigned to Ikena Oncology on October, 2022 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11458149	October 4, 2022
	‌ US Patent 11358969 Indole AHR inhibitors and uses thereof	Patent 11358969 was granted and assigned to Ikena Oncology on June, 2022 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11358969	June 14, 2022
	‌ US Patent 11608329 Aryl hydrocarbon receptor (AHR) agonists and uses thereof	Patent 11608329 was granted and assigned to Ikena Oncology on March, 2023 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11608329	March 21, 2023
	‌ US Patent 11591339 Solid forms of (R)-N-(2-(5-fluoropyridin-3-yl)-8-isopropylpyrazolo[ 1,5-a][1,3,5]triazin-4-yl)-2,3,4,9-tetrahydro-1H-carbazol-3-amine maleate as aryl hydrocarbon receptor (AHR) inhibitors		Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11591339	February 28, 2023
	‌ US Patent 11925651 TEAD inhibitors and uses thereof	Patent 11925651 was granted and assigned to Ikena Oncology on March, 2024 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11925651	March 12, 2024
	‌ US Patent 12077542 Indole AHR inhibitors and uses thereof	Patent 12077542 was granted and assigned to Ikena Oncology on September, 2024 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	12077542	September 3, 2024
	‌ US Patent 11878958 MEK inhibitors and uses thereof	Patent 11878958 was granted and assigned to Ikena Oncology on January, 2024 by the United States Patent and Trademark Office.	Ikena Oncology	Ikena Oncology		United States Patent and Trademark Office	11878958	January 23, 2024

10 results

0 selected

10 results

0 selected